Drugs / picosulphate
picosulphate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02009202 Comparator | Nov 2012 → Jun 2014 | inflammatory bowel disease | Skane University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | picosulphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02009202 ↗ |
| Known as | NaPico | “either polyethylene glycol (PEG) or sodium picosulphate (NaPico) (primary outcome)” PMID 26360658 ↗ Mar 2016 |
| Known as | sodium picosulphate | “either polyethylene glycol (PEG) or sodium picosulphate (NaPico) (primary outcome)” PMID 26360658 ↗ Mar 2016 |
| Route | Oral | “Picosulphate is given orally” NCT02009202 ↗ |